SCHEMBL19867723

SCHEMBL19867723

C=C(CC)Oc1cnc2[nH]ccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 2/20 0.47
▸ FGFR1 P11362 1/20 0.47
▸ RIPK1 Q13546 2/20 0.42
▸ CDK8 P49336 13/20 0.41
▸ AXL P30530 1/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ PLK4 O00444 1/20 0.39
▸ DCLK1 O15075 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ PRKD3 O94806 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ PAK4 O96013 1/20 0.39
▸ CHEK2 O96017 1/20 0.39
▸ INSR P06213 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ FES P07332 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL413709 0.79 KDR (0.54) KDRFGFR1RIPK1CDK8AXL
SCHEMBL27889595 0.78 ALDH1A1 (0.52) KDRFGFR1RIPK1CDK8AXL
SCHEMBL24775576 0.77 KDR (0.46) KDRFGFR1RIPK1CDK8AXL
SCHEMBL14856741 0.76 CDK8 (0.49) KDRFGFR1RIPK1CDK8AXL
SCHEMBL296198 0.75 KDR (0.65) KDRFGFR1RIPK1CDK8AXL
SCHEMBL29325780 0.72 FGFR1 (0.48) KDRFGFR1RIPK1CDK8AXL
SCHEMBL25469573 0.72 KDR (0.48) KDRFGFR1RIPK1CDK8AXL
SCHEMBL415173 0.72 KDR (0.54) KDRFGFR1RIPK1CDK8AXL
SCHEMBL24758368 0.72 FGFR1 (0.47) KDRFGFR1RIPK1CDK8AXL
SCHEMBL30845320 0.72 FGFR1 (0.47) KDRFGFR1RIPK1CDK8AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021078301-A1 PROTEIN DEGRADING AGENT AND USE THEREOF IN TREATMENT OF DISEASES 上海科技大学 2021-04-29 — — WO disclosed
WO-2019185025-A1 TRIFLUOROMETHYL-SUBSTITUTED SULFONAMIDE AS BCL-2-SELECTIVE INHIBITOR 正大天晴药业集团股份有限公司 2019-10-03 — — WO disclosed
WO-2018029711-A2 PROCESS FOR THE PREPARATION OF VENETOCLAX MYLAN LABORATORIES LIMITED (IN) 2018-02-15 — — WO disclosed
Send feedback